{
    "title": "China's approved COVID treatments",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11537239/Chinas-approved-COVID-treatments.html",
    "date": "2022-12-14",
    "keywords": [
        "china",
        "drug",
        "covid19",
        "platform",
        "treatment",
        "medication",
        "biotech",
        "july",
        "year",
        "evusheld",
        "demand",
        "online",
        "healthcare",
        "regulator",
        "approval",
        "group",
        "store",
        "company",
        "prevention",
        "use",
        "zone",
        "dec",
        "zerocovid",
        "evidence",
        "beijing",
        "chengdu",
        "flu",
        "pill",
        "box",
        "test",
        "result",
        "page",
        "app",
        "listing",
        "hour",
        "customer",
        "service",
        "officer",
        "product",
        "drugmaker",
        "health",
        "medicine",
        "infection",
        "adult",
        "condition",
        "yuan",
        "hepatitis",
        "virus",
        "latestage",
        "trial",
        "improvement",
        "control",
        "briefly",
        "november",
        "day",
        "statement",
        "countrys",
        "part",
        "conglomerate",
        "fosun",
        "tuesday",
        "pharma",
        "representative",
        "number",
        "home",
        "plcs",
        "antibody",
        "cocktail",
        "tourism",
        "province",
        "hainan",
        "astrazeneca",
        "tixagevimabcilgavimab",
        "december",
        "risk",
        "progression",
        "disease",
        "infusion",
        "therapy",
        "brii",
        "university",
        "hospital",
        "wuxi",
        "prescription",
        "yu",
        "roxanne",
        "liu",
        "brenda",
        "goh",
        "miyoung",
        "tom",
        "hogue"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}